aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
  • Tools
  • About
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
  • Tools
  • About
aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
  • Tools
  • About
  • Tech

IBM Offering Free Access To Patent Portfolio To Combat COVID-19

  • aster_cloud
  • April 22, 2020
  • 3 minute read

Technological ingenuity is playing a critical role in society’s response to the COVID-19 pandemic. Already, there are dozens of examples around the world of businesses, nonprofit organizations, government agencies, educators and individuals improvising and adapting technologies to meet their needs. Scientists, for example, are using supercomputers to accelerate COVID-19 drug discovery. Programmers are writing code to help with crisis communication, remote education and community cooperation. Meanwhile, industry and academia are 3-D printing face visors to address shortages in protective gear for healthcare professionals.

In the spirit of such innovation, IBM, the leading U.S. patent recipient for each of the last 27 years, is granting free access to its considerable patent portfolio to those developing technologies to help diagnose, prevent, contain or treat coronaviruses, including the one that causes COVID-19. Our pledge covers thousands of IBM AI patents, including Watson technology patents, as well as dozens of active U.S. patents in the general area of biological viruses


Partner with aster.cloud
for your next big idea.
Let us know here.


cyberpogo

One such patent describes anti-viral agents and methods of treatment using these agents. The anti-viral agents include cationic polyamines active against a broad spectrum of viruses, including Dengue, H1N1, SARS, influenza and coronaviruses. Other relevant patents, for example, describe a touchscreen that uses ultraviolet light for pathogen mitigation and algorithms for predicting the time and range of events, including epidemics.

IBM’s pledge will last for the life of our more than 80,000 patents and patent applications, and any new patent applications filed through the end of 2023 will likewise be covered by this commitment.

In promising to not assert IBM patents against entities using them in the fight against coronaviruses, IBM is joining the recent Open COVID Pledge as a founding adopter. The Open COVID Pledge calls on organizations to promise to make their intellectual property available free of charge for use in ending the current pandemic and minimizing the impact of the disease.

Read More  Did We Really Achieve Quantum Supremacy?

Our hope is that, in making our technology more widely available, we can provide valuable tools that innovators worldwide can use to help stop the spread of COVID-19 and better prepare us to meet any similar challenges we may face in the future.

IBM Coronavirus Pledge of Patent Non-Assertion

International Business Machines Corporation (IBM) makes the following pledge of patent non-assertion in order to help speed the development and dissemination of the technologies needed to end the COVID-19 pandemic and mitigate the effects of the disease, and with the intent that developers, users and distributors of such technologies may rely on this pledge. IBM covenants that it will not assert any Pledged Patent Claims against any person or entity for making, using, importing, selling, or offering for sale any machine, manufacture, process, or composition of matter solely for the purpose of diagnosing, preventing, containing, or treating COVID-19 or any disease in humans caused by a novel coronavirus as defined by the World Health Organization.

This non-assert covenant is effective as of December 1, 2019, and shall continue until the expiration of any IBM Patents that have Pledged Patent Claims. IBM may, at its option, terminate and render void ab initio this non-assert covenant as to any persons or entities who assert any patent against IBM, an IBM subsidiary, or their machines, manufactures, processes, or compositions of matter (including products and components thereof).


Our humans need coffee too! Your support is highly appreciated, thank you!

aster_cloud

Related Topics
  • COVID-19
  • IBM
  • Open COVID Pledge
You May Also Like
View Post
  • Tech

What Is Platform Engineering And Why Adopt It In Your Company?

  • June 1, 2023
View Post
  • Public Cloud
  • Software
  • Tech

Accelerate Smart Transformation To SAP S/4 HANA With Tata Consultancy Services Precast, Now For Google Cloud

  • May 15, 2023
View Post
  • Tech

Accelerating Cybersecurity Resilience Through The Expanded Accenture-Google Cloud Partnership

  • May 1, 2023
View Post
  • People
  • Tech

The 7 Best Top-Load And Front-Load Washers

  • April 26, 2023
View Post
  • Tech
  • Technology
  • Tools

Top 4 FREE Photo Editing Websites

  • April 18, 2023
View Post
  • Tech
  • Technology

DBS Singapore: The Best Boasting To Be The Best For So Long, Humbled By Hubris

  • March 31, 2023
View Post
  • Software
  • Tech
  • Technology

A New Smartphone Operating System That Puts Privacy First

  • March 10, 2023
View Post
  • Tech

Using IPv6 Unique Local Addresses For Private Connectivity In Google Cloud

  • January 24, 2023

Stay Connected!
LATEST
  • 1
    Predictions: Top 25 Careers Likely In High Demand In The Future
    • June 6, 2023
  • 2
    A S.W.O.T. Analysis Of Current A.I. Systems
    • June 6, 2023
  • Apple-WWCD23-Vision-Pro-glass-230605 3
    Introducing Apple Vision Pro: Apple’s first spatial compute
    • June 5, 2023
  • 4
    Apple Unveils New Mac Studio And Brings Apple Silicon To Mac Pro
    • June 5, 2023
  • 5
    Apple Introduces M2 Ultra
    • June 5, 2023
  • 6
    tvOS 17 Brings FaceTime And Video Conferencing To The Biggest Screen In The Home
    • June 5, 2023
  • 7
    Apple Introduces The 15‑Inch MacBook Air
    • June 5, 2023
  • 8
    Building A Kubernetes Platform: How And Why To Apply Governance And Policy
    • June 4, 2023
  • 9
    Leave, This “United” “Kingdom”, This “Great” “Britain”
    • June 4, 2023
  • 10
    Amazing Federated Multicloud Apps
    • June 2, 2023
about
Hello World!

We are aster.cloud. We’re created by programmers for programmers.

Our site aims to provide guides, programming tips, reviews, and interesting materials for tech people and those who want to learn in general.

We would like to hear from you.

If you have any feedback, enquiries, or sponsorship request, kindly reach out to us at:

[email protected]
Most Popular
  • 1
    Huawei ICT Competition 2022-2023 Global Final Held In Shenzhen — 146 Teams From 36 Countries And Regions Win Awards
    • May 27, 2023
  • 2
    Huawei OceanStor Pacific Scale-Out Storage Tops IO500 Rankings
    • May 26, 2023
  • 3
    What’s The Future Of DevOps? You Tell Us. Take The 2023 Accelerate State Of DevOps Survey
    • June 2, 2023
  • 4
    Resolving Deployment Issues With Ts-node And Azure Development Pipelines
    • June 1, 2023
  • 5
    MongoDB And Alibaba Cloud Extend Global Partnership
    • May 25, 2023
  • /
  • Technology
  • Tools
  • About
  • Contact Us

Input your search keywords and press Enter.